Stimulus-Responsive Drug Delivery Nanoplatforms for Osteoarthritis Therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Osteoarthritis (OA) is a prevalent age-related degenerative disease imposing significant economic and societal burdens.
• Conventional surgical and pharmacological treatments for OA often yield suboptimal outcomes.
• Aging global populations are increasing OA prevalence, necessitating novel therapeutic approaches.

Purpose of the Study:

• To review the advanced applications of stimulus-responsive nanoplatforms for osteoarthritis (OA) treatment.
• To categorize nanoplatforms based on endogenous or exogenous stimuli.
• To discuss opportunities, restrictions, and limitations of these nanodrug delivery systems.

Main Methods:

• Review of literature on stimulus-responsive nanoplatforms for OA.
• Categorization of nanoplatforms by stimulus type (endogenous: ROS, pH, enzyme, temperature; exogenous: NIR, ultrasound, magnetic fields).
• Analysis of multi-functionality, image guidance, and multi-stimulus response.

Main Results:

• Stimulus-responsive nanoplatforms offer enhanced control, retention, loading, and sensitivity for OA therapy.
• Endogenous stimulus-responsive systems target OA-specific microenvironments.
• Exogenous stimulus-responsive systems utilize external triggers for targeted drug release.

Conclusions:

• Stimulus-responsive nanoplatforms represent a promising advancement in OA therapeutic strategies.
• Further research is needed to address clinical application constraints and optimize multi-functional systems.
• Overcoming limitations in multi-functionality, image guidance, and multi-stimulus response is key for clinical translation.